Singapore markets close in 2 hours 18 minutes

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
8.23-0.18 (-2.14%)
At close: 04:00PM EST
8.20 -0.03 (-0.36%)
After hours: 05:45PM EST
Full screen
Trade prices are not sourced from all markets
Previous close8.41
Open8.42
Bid0.00 x 2200
Ask0.00 x 1800
Day's range8.22 - 8.51
52-week range7.73 - 13.30
Volume7,021,120
Avg. volume10,059,077
Market cap9.437B
Beta (5Y monthly)1.30
PE ratio (TTM)12.47
EPS (TTM)0.66
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend date27 Nov 2017
1y target est11.36
  • Motley Fool

    2 Best Warren Buffett Value Stocks to Buy Right Now

    Berkshire Hathaway CEO Warren Buffett is one of the most successful value investors of all time. Although classic value stocks fell out of favor during the nearly decade-long bull market over the course of 2010 to 2020, and Berkshire's stock underperformed some major U.S. stock indexes as a result, these tried and true investing vehicles are making a furious comeback during this current bear market. The long and short of it is that the increasing likelihood of rising interest rates and stubbornly high levels of inflation ought to favor Buffett's value-oriented approach to investing over narrative-driven growth stocks in 2022.

  • Motley Fool

    3 Turnaround Stocks That Can Bounce Back Big Time in 2022

    If we strictly looked at the performance of the major U.S. stock indexes, 2021 was a great year. While no investor enjoys seeing their stocks go in reverse, patience has a way of paying off handsomely in the stock market. In 2022, the following trio of turnaround stocks have the catalysts needed to bounce back in a big way.

  • Business Wire

    Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results and 2022 Financial Guidance at 8 a.m. ET on February 9, 2022

    TEL AVIV, Israel, January 18, 2022--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its fourth quarter and full year 2021 financial results, as well as on its financial guidance for 2022, on Wednesday, February 9, 2022 at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m. ET.